Citations (296)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (68)
A. Casiraghi, A. Calligaro, N. Zerbinati, M. Doglioli, A. F. Ruffolo, M. Candiani & S. Salvatore. (2023) Long-term clinical and histological safety and efficacy of the CO2 laser for treatment of genitourinary syndrome of menopause: an original study. Climacteric 26:6, pages 605-612.
Read now
Read now
A. Thurman, L. Hull, B. Stuckey, J. Hatheway, C. Mauck, N. Zack & D. Friend. (2023) Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy. Climacteric 26:5, pages 479-488.
Read now
Read now
R. Sánchez-Borrego, M. V. de Diego Pérez de Zabalza, M. J. Alfageme Gullón, M. L. Alija Castrillo, M. Sánchez Prieto, S. Palacios, A. J. González Calvo, J. J. Quijano Martín & M. J. Cancelo. (2023) Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA. Climacteric 26:5, pages 437-444.
Read now
Read now
S. Salvatore, A. F. Ruffolo, C. Phillips, S. Athanasiou, L. Cardozo & M. Serati. (2023) Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser. Climacteric 26:4, pages 336-352.
Read now
Read now
S. A. Kingsberg, B. Adler, J. Metropoulos & S. S. Faubion. (2023) The yin and yang of GSM and low sexual desire. Climacteric 26:4, pages 323-328.
Read now
Read now
J. Mercier, C. Dumoulin & G. Carrier-Noreau. (2023) Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?. Climacteric 26:4, pages 302-308.
Read now
Read now
Stefano Salvatore, Vittoria Benini, Alessandro Ferdinando Ruffolo, Rebecca S. Degliuomini, Anna Redaelli, Arianna Casiraghi & Massimo Candiani. (2023) Current challenges in the pharmacological management of genitourinary syndrome of menopause. Expert Opinion on Pharmacotherapy 24:1, pages 23-28.
Read now
Read now
L. M. Pompei, M. C. O. Wender, J. Kulak$suffix/text()$suffix/text(), I. Pires, Y. Suvarna & R. E. Nappi. (2021) Impact of postmenopausal vaginal discomfort on sex and relationships in Brazil: the CLOSER survey. Climacteric 24:6, pages 593-599.
Read now
Read now
Carmen Pingarron, Pilar de Lafuente, Antonio María Ierullo, Silvia Poyo Torcal, Carlos Javier Maroto Díaz & Santiago Palacios. (2021) Ospemifene in clinical practice for vulvo-vaginal atrophy: results at 3 months of follow-up of use. Gynecological Endocrinology 37:6, pages 562-566.
Read now
Read now
X. Ruan, L. Zhang, Y. Cui, M. Gu & A. O. Mueck. (2021) Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women. Climacteric 24:3, pages 297-304.
Read now
Read now
L. M. Pompei, M. C. O. Wender, N. R. de Melo, J. Kulak$suffix/text()$suffix/text(), D. Pardini, R. B. Machado, C. E. Fernandes, S. Palacios & R. E. Nappi. (2021) Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil. Climacteric 24:2, pages 157-163.
Read now
Read now
Rossella E. Nappi, Maurizio Guida, Diego Marchesoni, Antonio Cianci, Antonio Pellegrino, Valentino Remorgida, Tiziana Di Paolantonio & Pierluigi Benedetti Panici. (2021) Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women. Journal of Obstetrics and Gynaecology 41:2, pages 290-297.
Read now
Read now
Rossella E. Nappi, Santiago Palacios, Nico Bruyniks, Martire Particco & Nick Panay. (2021) The European Vulvovaginal Epidemiological Survey (EVES). Impact of history of breast cancer on prevalence, symptoms, sexual function and quality of life related to vulvovaginal atrophy. Gynecological Endocrinology 37:1, pages 78-82.
Read now
Read now
R. E. Nappi, M. Kotek, A. Brešt’anský, N. Giordan & E. Tramentozzi. (2020) Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Climacteric 23:5, pages 519-524.
Read now
Read now
Lino Del Pup & Rafael Sánchez-Borrego. (2020) Ospemifene efficacy and safety data in women with vulvovaginal atrophy. Gynecological Endocrinology 36:7, pages 569-577.
Read now
Read now
Rossella E. Nappi, Costantino Di Carlo, Angela Maria Becorpi, Marco Gambacciani, Francesco De Seta, Raffaella Ribaldone, Chiara Benedetto & Anna Maria Paoletti. (2020) The effect of vulvovaginal atrophy on women’s quality of life from an Italian cohort of the EVES study. Journal of Obstetrics and Gynaecology 40:4, pages 512-519.
Read now
Read now
I. Sriprasert, T. Pakrashi, A. Shah, T. Jacot, B. Bernick, S. Mirkin & D. F. Archer. (2020) A pilot study: estradiol/progesterone effect on cervico-vaginal cytokines in premenopause and postmenopause. Climacteric 23:3, pages 306-310.
Read now
Read now
F. Murina, R. Felice, S. Di Francesco, L. Nelvastellio & I. Cetin. (2020) Ospemifene plus fractional CO2 laser: a powerful strategy to treat postmenopausal vulvar pain. Gynecological Endocrinology 36:5, pages 431-435.
Read now
Read now
David F. Archer, James A. Simon, David J. Portman, Steven R. Goldstein & Irwin Goldstein. (2019) Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause. Expert Review of Endocrinology & Metabolism 14:5, pages 301-314.
Read now
Read now
J. A. Simon, R. Kagan, D. F. Archer, G. D. Constantine, B. Bernick, S. Graham & S. Mirkin. (2019) TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women. Climacteric 22:4, pages 412-418.
Read now
Read now
S. L. Johnston. (2019) Pelvic floor dysfunction in midlife women. Climacteric 22:3, pages 270-276.
Read now
Read now
C. Jung & L. Brubaker. (2019) The etiology and management of recurrent urinary tract infections in postmenopausal women. Climacteric 22:3, pages 242-249.
Read now
Read now
R. E. Nappi, R. Seracchioli, S. Salvatore, A. Cagnacci, T. Di Paolantonio & M. Busacca. (2019) Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study. Gynecological Endocrinology 35:5, pages 453-459.
Read now
Read now
D. J. Portman, S. R. Goldstein & R. Kagan. (2019) Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review. Climacteric 22:1, pages 65-72.
Read now
Read now
A. Cagnacci, A. Xholli, M. Sclauzero, M. Venier, F. Palma & M. Gambacciani. (2019) Vaginal atrophy across the menopausal age: results from the ANGEL study. Climacteric 22:1, pages 85-89.
Read now
Read now
Iuliia Naumova & Camil Castelo-Branco. (2018) Current treatment options for postmenopausal vaginal atrophy. International Journal of Women's Health 10, pages 387-395.
Read now
Read now
Ginger D. Constantine, James A. Simon, James H. Pickar, David F. Archer, Brian Bernick, Shelli Graham & Sebastian Mirkin. (2018) Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data. Current Medical Research and Opinion 34:12, pages 2131-2136.
Read now
Read now
J. A. Simon, S. R. Davis, S. E. Althof, P. Chedraui, A. H. Clayton, S. A. Kingsberg, R. E. Nappi, S. J. Parish & W. Wolfman. (2018) Sexual well-being after menopause: An International Menopause Society White Paper. Climacteric 21:5, pages 415-427.
Read now
Read now
R. E. Nappi, N. R. de Melo, M. Martino, C. Celis-González, P. Villaseca, S. Röhrich & S. Palacios. (2018) Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America. Climacteric 21:4, pages 397-403.
Read now
Read now
S. Palacios, R. E. Nappi, N. Bruyniks, M. Particco & N. Panay. (2018) The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric 21:3, pages 286-291.
Read now
Read now
E. Moral, J. L. Delgado, F. Carmona, B. Caballero, C. Guillán, P. M. González, J. Suárez-Almarza, S. Velasco-Ortega & C. Nieto. (2018) Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric 21:2, pages 167-173.
Read now
Read now
R. E. Nappi, A. Cagnacci, A. M. Becorpi, C. Nappi, A. M. Paoletti, M. Busacca, S. Martella, M. Bellafronte, Z. Tredici, C. Di Carlo, V. Corda, M. Vignali, M. Bagolan & M. Sardina. (2017) Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women. Climacteric 20:5, pages 467-475.
Read now
Read now
Federica Palma, Anjeza Xholli & Angelo Cagnacci. (2017) Management of vaginal atrophy: a real mess. Results from the AGATA study. Gynecological Endocrinology 33:9, pages 702-707.
Read now
Read now
G. P. Siliquini, V. Tuninetti, V. E. Bounous, F. Bert & N. Biglia. (2017) Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric 20:4, pages 379-384.
Read now
Read now
Y. Chua, K. K. Limpaphayom, B. Cheng, C. M. Ho, K. Sumapradja, C. Altomare & K. Huang. (2017) Genitourinary syndrome of menopause in five Asian countries: results from the Pan-Asian REVIVE survey. Climacteric 20:4, pages 367-373.
Read now
Read now
Rossella E. Nappi, Martire Particco, Nicoletta Biglia, Angelo Cagnacci, Costantino Di Carlo, Stefano Luisi & Anna Maria Paoletti. (2017) Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data. Gynecological Endocrinology 33:5, pages 389-394.
Read now
Read now
S. Palacios, M. J. Cancelo, C. Castelo Branco, P. Llaneza, F. Molero & R. Sanchez Borrego. (2017) Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions. Climacteric 20:1, pages 55-61.
Read now
Read now
F. Guidozzi, C. Thomas, T. Smith & R. E. Nappi. (2017) CLarifying vaginal atrophy’s impact On SEx and Relationships (CLOSER) survey in South Africa. Climacteric 20:1, pages 49-54.
Read now
Read now
Risa Kagan, Steven R Goldstein, James H Pickar & Barry S Komm. (2016) Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene. Therapeutics and Clinical Risk Management 12, pages 549-562.
Read now
Read now
Santiago Palacios & María Jesús Cancelo. (2016) Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. International Journal of Women's Health 8, pages 617-626.
Read now
Read now
F. Palma, E. Della Vecchia & A. Cagnacci. (2016) Medical and patient attitude towards vaginal atrophy: the AGATA study. Climacteric 19:6, pages 553-557.
Read now
Read now
Chiara Bondi, Simone Ferrero, Carolina Scala, Emanuela Tafi, Annalisa Racca, Pier Luigi Venturini & Umberto Leone Roberti Maggiore. (2016) Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause. Expert Opinion on Drug Metabolism & Toxicology 12:10, pages 1233-1246.
Read now
Read now
. (2016) Abstracts for 15th World Congress on Menopause. Climacteric 19:sup1, pages (iii)-(cxxix).
Read now
Read now
S. Athanasiou, E. Pitsouni, S. Antonopoulou, D. Zacharakis, S. Salvatore, M. E. Falagas & T. Grigoriadis. (2016) The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric 19:5, pages 512-518.
Read now
Read now
Rossella E. Nappi, Nicoletta Biglia, Angelo Cagnacci, Costantino Di Carlo, Stefano Luisi & Anna Maria Paoletti. (2016) Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group. Gynecological Endocrinology 32:8, pages 602-606.
Read now
Read now
R. E. Nappi & M. L. Krychman. (2016) The American–European difference in vulvar and vaginal atrophy views: a lesson from the REVIVE Survey. Climacteric 19:3, pages 252-255.
Read now
Read now
R. J. Baber, N. Panay & A. Fenton$suffix/text()$suffix/text(). (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 19:2, pages 109-150.
Read now
Read now
R. E. Nappi, S. Palacios, N. Panay, M. Particco & M. L. Krychman. (2016) Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric 19:2, pages 188-197.
Read now
Read now
F. Labrie, M. Montesino, D. F. Archer, L. Lavoie, A. Beauregard, I. Côté, C. Martel, M. Vaillancourt, J. Balser & E. Moyneur. (2015) Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner. Climacteric 18:6, pages 817-825.
Read now
Read now
N. Panay. (2015) Genitourinary syndrome of the menopause – dawn of a new era?. Climacteric 18:sup1, pages 13-17.
Read now
Read now
Rita Palmeira-de-Oliveira, Paulo Duarte, Ana Palmeira-de-Oliveira, José das Neves, Maria Helena Amaral, Luiza Breitenfeld & José Martinez-de-Oliveira. (2015) Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal. The European Journal of Contraception & Reproductive Health Care 20:4, pages 259-271.
Read now
Read now
P. Tuntiviriyapun, K. Panyakhamlerd, S. Triratanachat, T. Chatsuwan, S. Chaikittisilpa, U. Jaisamrarn & N. Taechakraichana. (2015) Newly developed vaginal atrophy symptoms II and vaginal pH: a better correlation in vaginal atrophy?. Climacteric 18:2, pages 246-251.
Read now
Read now
S. Salvatore, R. E. Nappi, M. Parma, R. Chionna, F. Lagona, N. Zerbinati, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2015) Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 18:2, pages 219-225.
Read now
Read now
Mary Jane Minkin, Ricardo Maamari & Suzanne Reiter. (2014) Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy. International Journal of Women's Health 6, pages 281-288.
Read now
Read now
Sarah H Lindahl. (2014) Reviewing the options for local estrogen treatment of vaginal atrophy. International Journal of Women's Health 6, pages 307-312.
Read now
Read now
D. J. Portman & M. L. S. Gass. (2014) Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society. Climacteric 17:5, pages 557-563.
Read now
Read now
S. Salvatore, R. E. Nappi, N. Zerbinati, A. Calligaro, S. Ferrero, M. Origoni, M. Candiani & U. Leone Roberti Maggiore. (2014) A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 17:4, pages 363-369.
Read now
Read now
Nick Panay & Anna Fenton. (2014) Vulvovaginal atrophy – a tale of neglect. Climacteric 17:1, pages 1-2.
Read now
Read now
R. E. Nappi & S. Palacios. (2014) Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 17:1, pages 3-9.
Read now
Read now
W. H. Utian & R. Maamari. (2014) Attitudes and approaches to vaginal atrophy in postmenopausal women: a focus group qualitative study. Climacteric 17:1, pages 29-36.
Read now
Read now
Ginger D. Constantine, Nico Bruyniks, Nicole Princic, Daniel Huse, Liisa Palmer, Greg Lenhart, William A. Blumentals & Rossella E. Nappi. (2014) Incidence of genitourinary conditions in women with a diagnosis of vulvar/vaginal atrophy. Current Medical Research and Opinion 30:1, pages 143-148.
Read now
Read now
Sharon J Parish, Rossella E Nappi, Michael L Krychman, Susan Kellogg-Spadt, James A Simon, Jeffrey A Goldstein & Sheryl A Kingsberg. (2013) Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. International Journal of Women's Health 5, pages 437-447.
Read now
Read now
Mary Jane Minkin, Ricardo Maamari & Suzanne Reiter. (2013) Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy. International Journal of Women's Health 5, pages 133-139.
Read now
Read now
Suzanne Reiter. (2013) Barriers to effective treatment of vaginal atrophy with local estrogen therapy. International Journal of General Medicine 6, pages 153-158.
Read now
Read now
J. A. Simon & R. V. Maamari. (2013) Ultra-low-dose vaginal estrogen tablets for the treatment of postmenopausal vaginal atrophy. Climacteric 16:sup1, pages 37-43.
Read now
Read now
T. J. de Villiers, A. Pines, N. Panay, M. Gambacciani, D. F. Archer, R. J. Baber, S. R. Davis, A. A. Gompel, V. W. Henderson, R. Langer, R. A. Lobo, G. Plu-Bureau & D. W. Sturdee. (2013) Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric 16:3, pages 316-337.
Read now
Read now
A. Sinha & A. A. A. Ewies. (2013) Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 16:3, pages 305-312.
Read now
Read now
S. R. Davis, C. Castelo-Branco, P. Chedraui, M. A. Lumsden, R. E. Nappi, D. Shah & P. Villaseca. (2012) Understanding weight gain at menopause. Climacteric 15:5, pages 419-429.
Read now
Read now
Articles from other publishers (228)
Saijun Qiu, Afiba Arthur, Yuchen Jiang, Yusi Miao, Yan Li, Jingyi Wang, Yona Tadir, Felicia Lane & Zhongping Chen. (2023) OCT angiography in the monitoring of vaginal health. APL Bioengineering 7:4.
Crossref
Crossref
Jenny Doust, Annabelle Huguenin & Martha Hickey. (2023) Genitourinary Syndrome of Menopause: Does Everyone Have It?. Clinical Obstetrics & Gynecology.
Crossref
Crossref
Susan J. Diem & Elisheva R. Danan. (2023) GSM and Quality of Life Measures. Clinical Obstetrics & Gynecology.
Crossref
Crossref
Vaibhavi B Wasnik, Neema Acharya & Shazia Mohammad. (2023) Genitourinary Syndrome of Menopause: A Narrative Review Focusing on Its Effects on the Sexual Health and Quality of Life of Women. Cureus.
Crossref
Crossref
Mengqi Huang, Yidan Wang, Jiajun Xu, Huiru Xiao & Jingyan Xie. (2023) Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe. European Journal of Medical Research 28:1.
Crossref
Crossref
Ramadan Abdelmoez Farahat, Hazem Mohamed Salamah, Abdelrahman Mahmoud, Esraa Hamouda, Mahmoud Hashemy, Heba Hamouda, Ali Samir, Imane Chenfouh, Ahmed Marey, Dina M. Awad, Elsayed Farag, Mohamed Abd-Elgawad & Elsayed Eldesouky. (2023) The efficacy of oxytocin gel in postmenopausal women with vaginal atrophy: an updated systematic review and meta-analysis. BMC Women's Health 23:1.
Crossref
Crossref
Parker Foster, Marie Luebke, Abrahim N. Razzak, Danyon J. Anderson, Jamal Hasoon, Omar Viswanath, Alan D. Kaye & Ivan Urits. (2023) Stigmatization as a Barrier to Urologic Care: A Review. Health Psychology Research 11.
Crossref
Crossref
Caroline Mitchell. (2023) Evaluation and treatment of vulvovaginal itching in postmenopausal women. Menopause 30:9, pages 969-971.
Crossref
Crossref
Daniel M. Lubián-López, Carmen A. Butrón-Hinojo, Salomón Menjón-Beltrán, Ernesto González-Mesa, Silvia Tapiador-Albertos, Bibiana Rodríguez-Jiménez & Gabriel Fiol-Ruiz. (2023) Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. Journal of Clinical Medicine 12:17, pages 5669.
Crossref
Crossref
Felice Moccia, Paola Pentangelo, Alessandra Ceccaroni, Antonio Raffone, Luigi Losco & Carmine Alfano. (2023) Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review. Aesthetic Plastic Surgery.
Crossref
Crossref
Caroline M. Mitchell, Joseph C. Larson, Susan D. Reed & Katherine A. Guthrie. (2023) The complexity of genitourinary syndrome of menopause: number, severity, and frequency of vulvovaginal discomfort symptoms in women enrolled in a randomized trial evaluating treatment for genitourinary syndrome of menopause. Menopause 30:8, pages 791-797.
Crossref
Crossref
Nicoletta Gelli & Hilary Abbey. (2023) “It's all about the story”. Osteopaths' experiences of exploring menopausal symptoms: A qualitative interview study. International Journal of Osteopathic Medicine 48, pages 100657.
Crossref
Crossref
Anna Gosset, Jeanne Marie Claeys, Eric Huyghe & Florence Tremollieres. (2023) Sexual function and quality of life in women with idiopathic premature ovarian insufficiency. The Journal of Sexual Medicine 20:5, pages 626-632.
Crossref
Crossref
A.-C. Pizzoferrato & X. Fritel. (2023) Prise en charge des troubles de la statique pelvienne chez la femme ménopausée : le point de vue du gynécologue. La Presse Médicale Formation 4:1, pages 72-80.
Crossref
Crossref
Isaac Mensah Bonsu, Hellen Myezwa, Corlia Brandt, Adedayo Tunde Ajidahun, Monday Omoniyi Moses & Benjamin Asamoah. (2023) An exploratory study on excess weight gain: Experiences of Postmenopausal Women in Ghana. PLOS ONE 18:1, pages e0278935.
Crossref
Crossref
Lesley L. Green-Rennis, Lisa Grace-Leitch & Gloria Shine McNamara. 2023. Black Women's Reproductive Health and Sexuality. Black Women's Reproductive Health and Sexuality.
Rossella E. Nappi, Emad Siddiqui, Lora Todorova, Carol Rea, Eric Gemmen & Neil M. Schultz. (2023) Prevalence and quality-of-life burden of vasomotor symptoms associated with menopause: A European cross-sectional survey. Maturitas 167, pages 66-74.
Crossref
Crossref
Akanksha Goyal, Pratima Gupta & David W. Sturdee. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Luwam Ghidei, Pardis Hosseinzadeh & Terri L. Woodard. 2020. Handbook of Gynecology. Handbook of Gynecology
1
16
.
Luwam Ghidei, Pardis Hosseinzadeh & Terri L. Woodard. 2023. Handbook of Gynecology. Handbook of Gynecology
685
700
.
Ye Zhu, Junxiu Wei, Xin Yang, Wei Zhu & Weiting Zhang. (2022) Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study. BMC Women's Health 22:1.
Crossref
Crossref
Masakazu Terauchi, Tamami Odai, Kiyoko Kato & Naoyuki Miyasaka. (2022) Body weight and body fat are negatively associated with severe dyspareunia in postmenopausal women. Journal of Obstetrics and Gynaecology Research 48:12, pages 3279-3285.
Crossref
Crossref
Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach & Evgeny D. Dolgov. (2022) Vulvovaginal atrophy in the peri- and post-menopause: relevance and impact on quality of life. Gynecology 24:5, pages 408-412.
Crossref
Crossref
Ji-Eun Lee, Wan-Jae Lee, Yun-Hwan Lee & Ho-Seong Lee. (2022) Effects of Weight-Bearing Exercise on Health-Related Physical Fitness and Sleep Indicators in Pre- and Postmenopausal Women. Exercise Science 31:4, pages 545-552.
Crossref
Crossref
Burcu Sert & Serap Özgül. (2022) Turkish day-to-day impact of vaginal aging questionnaire: reliability, validity and relationship with pelvic floor distress. International Urogynecology Journal 33:11, pages 3093-3102.
Crossref
Crossref
O. V. Yakushevskaya. (2022) Menopause and genitourinary health: optimal support and correction of disorders. Meditsinskiy sovet = Medical Council:16, pages 136-141.
Crossref
Crossref
Doaa M. Saleh & Rania Abdelghani. (2022) Clinical evaluation of autologous platelet rich plasma injection in postmenopausal vulvovaginal atrophy: A pilot study. Journal of Cosmetic Dermatology 21:10, pages 4269-4275.
Crossref
Crossref
Julia von Schell & Markus Hübner. (2022) Vaginale Atrophie. gynäkologie + geburtshilfe 27:5, pages 26-31.
Crossref
Crossref
F.A. Trémollieres, N. Chabbert-Buffet, G. Plu-Bureau, C. Rousset-Jablonski, J.M. Lecerf, M. Duclos, J.M. Pouilles, A. Gosset, G. Boutet, C. Hocke, E. Maris, J. Hugon-Rodin, L. Maitrot-Mantelet, G. Robin, G. André, N. Hamdaoui, C. Mathelin, P. Lopes, O. Graesslin & X. Fritel. (2022) Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines. Maturitas 163, pages 62-81.
Crossref
Crossref
Carolyn J. Crandall, Joseph C. Larson, Kristine E. Ensrud, Andrea Z. LaCroix, Katherine A. Guthrie, Susan D. Reed, Shalender Bhasin & Susan Diem. (2022) Are serum estrogen concentrations associated with menopausal symptom bother among postmenopausal women? Baseline results from two MsFLASH clinical trials. Maturitas 162, pages 23-30.
Crossref
Crossref
Elizabeth E. Stanley & Rachel J. Pope. (2022) Characteristics of Female Sexual Health Programs and Providers in the United States. Sexual Medicine 10:4, pages 100524-100524.
Crossref
Crossref
Gargi MukherjeeVaishnavi NatarajanAnindita Chakrabarty. (2022) Menopausal hormone-replacement therapy and breast cancer risk: An updated and simplified view. Journal of Reproductive Healthcare and Medicine 3, pages 4.
Crossref
Crossref
Vittoria Benini, Alessandro Ruffolo, Arianna Casiraghi, Rebecca Degliuomini, Matteo Frigerio, Andrea Braga, Maurizio Serati, Marco Torella, Massimo Candiani & Stefano Salvatore. (2022) New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. Medicina 58:6, pages 770.
Crossref
Crossref
Olivia Engholt Mortensen, Sarah Emilie Christensen & Ellen Løkkegaard. (2022)
The evidence behind the use of
LASER
for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state‐of‐the‐art review
. Acta Obstetricia et Gynecologica Scandinavica 101:6, pages 657-692.
Crossref
Crossref
Abbie J. Laing, Louise Newson & James A. Simon. (2022) Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development. The Cancer Journal 28:3, pages 196-203.
Crossref
Crossref
Paula Briggs. (2022) Consensus statement – Urogenital atrophy. Post Reproductive Health 28:1, pages 47-50.
Crossref
Crossref
Rita Palmeira-de-Oliveira, Ana Sofia Oliveira, Joana Rolo, Mariana Tomás, Ana Palmeira-de-Oliveira, Sérgio Simões & José Martinez-de-Oliveira. (2022) Women’s preferences and acceptance for different drug delivery routes and products. Advanced Drug Delivery Reviews 182, pages 114133.
Crossref
Crossref
Daniel María Lubián López. (2022) Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World Journal of Clinical Oncology 13:2, pages 71-100.
Crossref
Crossref
Svetlana Jankovic. 2022. Insights Into Incontinence and the Pelvic Floor. Insights Into Incontinence and the Pelvic Floor
201
207
.
Jill Krapf, Ann Nwabuebo & Lucia Miller. 2022. Each Woman’s Menopause: An Evidence Based Resource. Each Woman’s Menopause: An Evidence Based Resource
257
282
.
Sergei I. Surkichin, Larisa S. Kruglova, Inna A. Apolikhina, Roman Yu. Mayorov & Marika Avin. (2021) Involutive changes in the vulvovaginal area. Russian Journal of Physiotherapy, Balneology and Rehabilitation 20:2, pages 161-174.
Crossref
Crossref
Laura Baquedano Mainar, Sonia Sánchez Méndez, Peña Dieste Pérez, Mónica Hernández Aragón, Nicolás Mendoza Ladrón de Guevara, L. Baquedano, A. Espiau, S. Ortega, L. Ruiz, M. Lamarca, Y. José, P. Rubio, F. Villalobos, A. Borque, P. Dieste, L. Gabasa, V. Roy, M. J. Puente, M. Chóliz, L. Cotaina, I. Negredo, P. del Tiempo, H. Yagüe, M. Hernández, P. Tajada, M. Fasero, I. Ramirez, L. Gutiérrez, F. Colmenarejo, P. Coronado, T. Aznar, J. Presa, P. Llaneza, R. Sánchez Borrego, S. Palacios & Ana R. Jurado. (2021) Women's knowledge about the genitourinary syndrome of menopause: adherence to its treatments in the COVID-19 era in a sample of them: COMEM-GSM study. BMC Women's Health 21:1.
Crossref
Crossref
Rossella E. Nappi, Laura Cucinella, Ellis Martini & Chiara Cassani. (2021) The role of hormone therapy in urogenital health after menopause. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101595.
Crossref
Crossref
Guglielmo Stabile, Giuseppe Ricci, Maria Sole Scalia & Francesco De Seta. (2021) Induced Dryness Stress on Human Vaginal Epithelium: The Efficacy of a New Vaginal Gel. Gels 7:4, pages 157.
Crossref
Crossref
Kun-Ling Lin, Jian-He Lu, Kuang-Shun Chueh, Tai-Jui Juan, Bin-Nan Wu, Shu-Mien Chuang, Yung-Chin Lee, Mei-Chen Shen, Cheng-Yu Long & Yung-Shun Juan. (2021) Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial. International Journal of Molecular Sciences 22:17, pages 9296.
Crossref
Crossref
Maria Grazia Matarazzo, Giuseppe Sarpietro, Debora Fiorito, Salvatore Di Pasqua, Simona Ingrassano, Marco Marzio Panella, Antonio Cianci & Salvatore Caruso. (2021) Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology 263, pages 67-71.
Crossref
Crossref
Tassahil Messas, Achraf Messas & George Kroumpouzos. (2021) Carbon Dioxide Laser Vulvovaginal Rejuvenation: A Systematic Review. Cosmetics 8:3, pages 56.
Crossref
Crossref
Nikoletta Mili, Stavroula A. Paschou, Anastasia Armeni, Neoklis Georgopoulos, Dimitrios G. GoulisIrene Lambrinoudaki. (2021) Genitourinary syndrome of menopause: a systematic review on prevalence and treatment. Menopause 28:6, pages 706-716.
Crossref
Crossref
Zhifang Zheng, Junfeiyang Yin, Biao Cheng & Wenhua Huang. (2021) Materials Selection for the Injection into Vaginal Wall for Treatment of Vaginal Atrophy. Aesthetic Plastic Surgery 45:3, pages 1231-1241.
Crossref
Crossref
Anıl TURHAN ÇAKIR. (2021) Vajinal Pap-Smear Test Sonucu Atrofi Olan Hastaların Klinik Özelliklerinin Değerlendirilmesi. Batı Karadeniz Tıp Dergisi 5:2, pages 132-136.
Crossref
Crossref
Gian Piero Siliquini, Valentina Elisabetta Bounous, Lorenzo Novara, Margherita Giorgi, Fabrizio Bert & Nicoletta Biglia. (2021) Fractional CO₂ vaginal laser for the genitourinary syndrome of menopause in breast cancer survivors. The Breast Journal 27:5, pages 448-455.
Crossref
Crossref
Nancy A. Phillips & Gloria A. Bachmann. (2021) The genitourinary syndrome of menopause. Menopause 28:5, pages 579-588.
Crossref
Crossref
C. Hocké, M. Diaz, V. Bernard, S. Frantz, M. Lambert, C. Mathieu & M. Grellety-Cherbero. (2021) Syndrome génito-urinaire de la ménopause (SGUM). RPC les femmes ménopausées du CNGOF et du GEMVi. Gynécologie Obstétrique Fertilité & Sénologie 49:5, pages 394-413.
Crossref
Crossref
I-Hsuan Yang, I-En Lin, Tzu-Chien Chen, Zhi-Yu Chen, Che-Yung Kuan, Jhih-Ni Lin, Yu-Chia Chou & Feng-Huei Lin. (2021) Synthesis, characterization, and evaluation of BDDE crosslinked chitosan-TGA hydrogel encapsulated with genistein for vaginal atrophy. Carbohydrate Polymers 260, pages 117832.
Crossref
Crossref
Ying Sheng, Janet Carpenter, Andrea Cohee, Susan Storey, Timothy Stump, Patrick Monahan, David Cella & Victoria Champion. (2021) Genitourinary Symptoms in Breast Cancer Survivors: Prevalence, Correlates, and Relationship With Sexual Functioning. Oncology Nursing Forum 48:2, pages 229-241.
Crossref
Crossref
Fiona Li, Vanessa Picard-Fortin, Sarah Maheux-Lacroix, Rebecca Deans, Erin Nesbitt-Hawes, Lalla McCormack & Jason Abbott. (2021) The Efficacy of Vaginal Laser and Other Energy-based Treatments on Genital Symptoms in Postmenopausal Women: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology 28:3, pages 668-683.
Crossref
Crossref
Zeyneb BAKACAK. (2021) The efficacy of fractional CO2 laser (FemiLift™) treatment in postmenopausal females with vulvovaginal atrophy: Preliminary results from a single center in TurkeyPostmenopozal Vulvovajinal Atrofi Saptanan Kadınlarda Fraksiyonel CO2 Lazer (Femilift™) Tedavisinin Etkinliği: Türkiye'den Tek Bir Merkezin Ön Sonuçları. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi 16:1, pages 96-100.
Crossref
Crossref
Xiaoyan Sun, Rui Zhang, Lirong Wang, Xiping Shen, Yongbin Lu, Junxia An, Liyan Wang, Yiqing Wang, Xiaorong Luo, Haiying Zhu & Xuehong Zhang. (2020) Association Between Parity and the Age at Menopause and Menopausal Syndrome in Northwest China. Asia Pacific Journal of Public Health 33:1, pages 60-66.
Crossref
Crossref
Joshua Morris, Cassidy Clark, Laura Reed, Diane Pace, Xueyuan Cao & Pallavi Khanna. (2021) Healthcare provider knowledge, attitudes, and preferences in management of genitourinary syndrome of menopause in the Mid-South. Menopause 28:11, pages 1239-1246.
Crossref
Crossref
Christine M. Derzko, Sebastian Röhrich & Nick Panay. (2021) Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets. Menopause 28:2, pages 113-118.
Crossref
Crossref
Kimberly K. Vesco, Michael C. Leo, Joanna E. Bulkley, Kate R. Beadle, Ashley B. Stoneburner, Melanie Francisco & Amanda L. Clark. (2021) Improving management of the genitourinary syndrome of menopause: evaluation of a health system–based, cluster-randomized intervention. American Journal of Obstetrics and Gynecology 224:1, pages 62.e1-62.e13.
Crossref
Crossref
Rebecca A. Shelby, Jessica N. Coleman, Sarah S. Arthur, Kelly S. Acharya, Amanda A. Heath, Margaret D. Flather, Kelly E. Westbrook & Caroline S. Dorfman. 2021. Common Issues in Breast Cancer Survivors. Common Issues in Breast Cancer Survivors
47
84
.
Richard Flint & Cathy Davis. 2021. Sexual Function and Pelvic Floor Dysfunction. Sexual Function and Pelvic Floor Dysfunction
65
81
.
Makeba Williams. 2021. Challenges in Older Women’s Health. Challenges in Older Women’s Health
1
14
.
Ahkam Göksel Kanmaz, Abdurrahman Hamdi İnan, Emrah Beyan, Adnan Budak, Emrah Töz, Murat Alan & Mehmet Özeren. (2020) Transabdominal ultrasonography: A non-invasive method for diagnosing vaginal atrophy. Post Reproductive Health 26:4, pages 220-226.
Crossref
Crossref
John S. Fisher, Andrew Rezk, Elie Nwefo, John Masterson & Ranjith Ramasamy. (2020) Sexual Health in the Elderly Population. Current Sexual Health Reports 12:4, pages 381-388.
Crossref
Crossref
Jennie Mastroianni, Julie A. Thompson, Jan L. ShifrenAndrea L. Zuckerman & Katherine Pereira. (2020) Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire. Menopause 27:11, pages 1295-1301.
Crossref
Crossref
E. V. Tikhomirova, V. E. Balan & O. S. Fomina-Nilova. (2020) Current treatment options for genitourinary syndrome. Meditsinskiy sovet = Medical Council:13, pages 91-96.
Crossref
Crossref
Julia Z. Guo, Colby Souders, Lynn McClellandJennifer T. Anger, Victoria C.S. Scott, Karyn S. Eilber & A. Lenore Ackerman. (2020) Vaginal laser treatment of genitourinary syndrome of menopause: does the evidence support the FDA safety communication?. Menopause 27:10, pages 1177-1184.
Crossref
Crossref
Ismail Selvi, Numan Baydilli, Dilek Yuksel, Emre Can Akinsal & Halil Basar. (2020) Reappraisal of the Definition Criteria for “Genitourinary Syndrome of Menopause,” and its Effect on Quality of Life in Turkish Postmenopausal Women. Urology 144, pages 83-91.
Crossref
Crossref
Rachel S. Rubin & James A. Simon. 2020. Female Sexual Pain Disorders. Female Sexual Pain Disorders
251
259
.
Prasong Tanmahasamut, Titima Jirasawas, Somsak Laiwejpithaya, Chatchai Areeswate, Chongdee Dangrat & Kittayaporn Silprasit. (2020) Effect of estradiol vaginal gel on vaginal atrophy in postmenopausal women: A randomized double‐blind controlled trial. Journal of Obstetrics and Gynaecology Research 46:8, pages 1425-1435.
Crossref
Crossref
Yun‐Fei Ge, Chun‐Hong Wei, Wei‐Hao Wang & Long‐Kui Cao. (2020) The resistant starch from sorghum regulates lipid metabolism in menopausal rats via equol. Journal of Food Biochemistry 44:8.
Crossref
Crossref
Beth L. Nordstrom, Bin Cai, Fabio De Gregorio, Nafeesa Dhalwani, Kathy H. Fraeman, Yuki YoshidaTrevor Gibbs. (2020) Incidence of venous thromboembolism among postmenopausal women prescribed ospemifene, selective estrogen receptor modulators for noncancer indications, or untreated vulvar and vaginal atrophy. Menopause 27:8, pages 864-871.
Crossref
Crossref
Claudine Domoney, Hannah Short, Martire Particco & Nick Panay. (2020) Symptoms, attitudes and treatment perceptions of vulvo-vaginal atrophy in UK postmenopausal women: Results from the REVIVE-EU study. Post Reproductive Health 26:2, pages 101-109.
Crossref
Crossref
Xanya Sofra & Nuris Lampe. (2020) Empowering the woman: a comprehensive model of sexual anti-ageing. Journal of Aesthetic Nursing 9:3, pages 118-127.
Crossref
Crossref
L. Photiou, M.J. Lin, D.P. Dubin, V. Lenskaya & H. Khorasani. (2019) Review of non‐invasive vulvovaginal rejuvenation. Journal of the European Academy of Dermatology and Venereology 34:4, pages 716-726.
Crossref
Crossref
Martire Particco, Stora Djumaeva, Rossella E. Nappi, Nick Panay & Santiago Palacios. (2020) The European Vulvovaginal Epidemiological Survey (EVES): impact on sexual function of vulvovaginal atrophy of menopause. Menopause 27:4, pages 423-429.
Crossref
Crossref
Sheryl A. Kingsberg, Lisa C. Larkin & James H. Liu. (2020) Clinical Effects of Early or Surgical Menopause. Obstetrics & Gynecology 135:4, pages 853-868.
Crossref
Crossref
Sarah Hillery. (2020) The impact of genitourinary syndrome of menopause on continence. British Journal of Nursing 29:6, pages 342-344.
Crossref
Crossref
Diane Todd Pace, Lisa Astalos Chism, Shelli Graham & Julia Amadio. (2020) How Nurse Practitioners Approach Treatment of Genitourinary Syndrome of Menopause. The Journal for Nurse Practitioners 16:2, pages 136-142.
Crossref
Crossref
James A. Simon. (2020) Depression, anxiety, and “the incredible shrinking vagina”∗. Menopause 27:2, pages 125-126.
Crossref
Crossref
Carolyn J. Crandall, Allison Diamant & Nanette Santoro. (2020) Safety of vaginal estrogens: a systematic review. Menopause 27:3, pages 339-360.
Crossref
Crossref
Maurizio Filippini, Daniela Luvero, Stefano Salvatore, Annalisa PieralliRoberto Montera, Francesco Plotti, Massimo Candiani & Roberto Angioli. (2020) Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause 27:1, pages 43-49.
Crossref
Crossref
Marie Fidela R. Paraiso, Cecile A. Ferrando, Eric R. Sokol, Charles R. Rardin, Catherine A. Matthews, Mickey M. Karram & Cheryl B. Iglesia. (2020) A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial. Menopause 27:1, pages 50-56.
Crossref
Crossref
John Paciuc. 2020. Hormonal Pathology of the Uterus. Hormonal Pathology of the Uterus
89
120
.
Sasivimol Srisukho, Tawiwan Pantasri, Wirawit Piyamongkol, Chailert Phongnarisorn & Nuntana Morakote. (2019) The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue. International Urogynecology Journal 30:11, pages 1843-1847.
Crossref
Crossref
Sharon J. Parish, Stephanie S. Faubion, Marc WeinbergBrian BernickSebastian Mirkin. (2019) The MATE survey: men's perceptions and attitudes towards menopause and their role in partners’ menopausal transition. Menopause 26:10, pages 1110-1116.
Crossref
Crossref
Risa Kagan, Susan Kellogg-Spadt & Sharon J. Parish. (2019) Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause. Drugs & Aging 36:10, pages 897-908.
Crossref
Crossref
Stefania Alvisi, Giulia Gava, Isabella Orsili, Giulia Giacomelli, Maurizio Baldassarre, Renato Seracchioli & Maria Cristina Meriggiola. (2019) Vaginal Health in Menopausal Women. Medicina 55:10, pages 615.
Crossref
Crossref
Irene Scavello, Elisa Maseroli, Vincenza Di Stasi & Linda Vignozzi. (2019) Sexual Health in Menopause. Medicina 55:9, pages 559.
Crossref
Crossref
Irwin Goldstein, James A. Simon, Andrew M. Kaunitz, Corrado Altomare, Yuki Yoshida, Julie Zhu, Sam Schaffer & Graziella Soulban. (2019) Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices. Menopause 26:9, pages 994-1001.
Crossref
Crossref
Rossella E. Nappi, Ellis Martini, Laura Cucinella, Silvia Martella, Lara Tiranini, Alessandra Inzoli, Emanuela Brambilla, David Bosoni, Chiara Cassani & Barbara Gardella. (2019) Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women. Frontiers in Endocrinology 10.
Crossref
Crossref
Santiago Palacios, Rossella E. Nappi, Marla Shapiro, Nilson Roberto de Melo, María Celeste Osorio Wender, César Eduardo Fernandes, Dolores Pardini, Rogério Bonassi Machado, Jaime Kulak, Cuauhtémoc Celis-González, Mabel T. Martino, Rita R. Pizzi, Paulina Villaseca, Eduardo Storch, Luis Fernando Danckers & José Alberto Hernández-Bueno. (2019) An individualized approach to the management of vaginal atrophy in Latin America. Menopause 26:8, pages 919-928.
Crossref
Crossref
Devon Evans, Susan Goldstein, Amanda Loewy & Alon D. Altman. (2019) No 385 - Indications de l'examen pelvien. Journal of Obstetrics and Gynaecology Canada 41:8, pages 1235-1250.
Crossref
Crossref
Devon Evans, Susan Goldstein, Amanda Loewy & Alon D. Altman. (2019) No. 385-Indications for Pelvic Examination. Journal of Obstetrics and Gynaecology Canada 41:8, pages 1221-1234.
Crossref
Crossref
Young-A Heo. (2019) Prasterone: A Review in Vulvovaginal Atrophy. Drugs & Aging 36:8, pages 781-788.
Crossref
Crossref
Houda ElfaneMohamed MziwiraKhadija SahelSanaa El JamalNadia El MahriLoubna Arkoubi IdrissiAdil Kalili, Naima ErrabahiRachida MoustakimRachida ElouafiKaoutar NaciriAzz El Arab AhajiMohammed El AyachiRekia Belahsen. (2019) Association of obesity with the lower limbs osteoarthritis in a community of women from El Jadida Province in Morocco. The North African Journal of Food and Nutrition Research 3:5, pages 156-163.
Crossref
Crossref
. (2019) Female Sexual Dysfunction. Obstetrics & Gynecology 134:1, pages e1-e18.
Crossref
Crossref
Raymond J. LanzafameSarah de la TorreGustavo H. Leibaschoff. (2019) The Rationale for Photobiomodulation Therapy of Vaginal Tissue for Treatment of Genitourinary Syndrome of Menopause: An Analysis of Its Mechanism of Action, and Current Clinical Outcomes. Photobiomodulation, Photomedicine, and Laser Surgery 37:7, pages 395-407.
Crossref
Crossref
David F. Archer, Steven R. Goldstein, James A. Simon, Arthur S. Waldbaum, Steven A. Sussman, Corrado Altomare, Julie Zhu, Yuki Yoshida, Sam Schaffer & Graziella Soulban. (2019) Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial. Menopause 26:6, pages 611-621.
Crossref
Crossref
Joanie Mercier, Mélanie Morin, Barbara Reichetzer, Marie-Claude Lemieux, Samir Khalifé & Chantale Dumoulin. (2019) Genitourinary syndrome of menopause symptom severity and impact outcome measures: are they reliable and correlated?. Menopause 26:6, pages 659-664.
Crossref
Crossref
Francisco L. Canales & Heather J. Furnas. (2019) Nonsurgical Vaginal Treatments. Advances in Cosmetic Surgery 2:1, pages 195-201.
Crossref
Crossref
No Author. (2019) Chapitre 5 : Santé urogénitale. Journal of Obstetrics and Gynaecology Canada 41, pages S73-S81.
Crossref
Crossref
Santiago Palacios, Silvia P. González, Micaela Fernández-Abellán, Montserrat Manubens, Pascual García-Alfaro, C.Argudo Prieto, L.Baquedano Mainar, J.Calleja Abu-Amshah, M.J.Cancelo Hidalgo, C. Castelo-Branco i Flores, P.Coronado Martin, M.Correa Rancel, M.Fernández Abellán, J.M.Fernández Moya, P.García Alfaro, M.González Fernández, S.González Rodríguez, E.Iglesias Bravo, P.Llaneza Coto, M.Manubens Grau, P.Marín Sánchez, N.Mendoza Ladrón de Guevara, B.Otero García-Ramos, S. Palacios, J.C.Presa Lorite, R.Sánchez Borrego, S.Sánchez Méndez & F.Vázquez Fernández. (2019) Impact Of Vulvovaginal Atrophy Of Menopause In Spanish Women: Prevalence And Symptoms According To The EVES Study. Sexual Medicine 7:2, pages 207-216.
Crossref
Crossref
Mary K. Barger. (2019) Current Resources for Evidence‐Based Practice, May/June, 2019. Journal of Midwifery & Women's Health 64:3, pages 347-351.
Crossref
Crossref
Rossella E. Nappi, Santiago Palacios, Nico Bruyniks, Martire Particco & Nick Panay. (2019) The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey. Menopause 26:5, pages 485-491.
Crossref
Crossref
Mario PretiPedro Vieira-Baptista, Giuseppe Alessandro DigesuCarol Emi BretschneiderMargot Damaser, Oktay DemirkesenDebra S. HellerNaside Mangir, Claudia MarchitelliSherif MouradMicheline Moyal-BarraccoSol PeremateuVisha TailorTufan TarcanElise J. B. De & Colleen K. Stockdale. (2019) The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document. Journal of Lower Genital Tract Disease 23:2, pages 151-160.
Crossref
Crossref
LaTina J. WatsonKaitlyn E. JamesIda J. Hatoum Moeller & Caroline M. Mitchell. (2019) Vulvovaginal Discomfort Is Common in Both Premenopausal and Postmenopausal Women. Journal of Lower Genital Tract Disease 23:2, pages 164-169.
Crossref
Crossref
Sheryl A. KingsbergJonathan SchaffirBrooke M. FaughtJoAnn V. PinkertonSharon J. ParishCheryl B. IglesiaJennifer GudemanJulie KropJames A. Simon. (2019) Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient–Clinician Communications. Journal of Women's Health 28:4, pages 432-443.
Crossref
Crossref
Priyanka SinghChristopher Yew Luen ChongHow Chuan Han. (2019) Effects of Vulvovaginal Laser Therapy on Postmenopausal Vaginal Atrophy: A Prospective Study. Journal of Gynecologic Surgery 35:2, pages 99-104.
Crossref
Crossref
Kimberly K. VescoKate BeadleAshley Stoneburner, Joanna Bulkley, Michael C. Leo & Amanda L. Clark. (2019) Clinician knowledge, attitudes, and barriers to management of vulvovaginal atrophy: variations in primary care and gynecology. Menopause 26:3, pages 265-272.
Crossref
Crossref
Violante Di Donato, Michele Carlo Schiavi, Valentina Iacobelli, Ottavia D’oria, Evangelos Kontopantelis, Tommaso Simoncini, Ludovico Muzii & Pierluigi Benedetti Panici. (2019) Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part II: Evaluation of tolerability and safety. Maturitas 121, pages 93-100.
Crossref
Crossref
Sharon J. Parish, Cindy M. Meston, Stanley E. Althof, Anita H. Clayton, Irwin Goldstein, Sue W. Goldstein, Julia R. Heiman, Marita P. McCabe, R. Taylor Segraves & James A. Simon. (2019) Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions—Part III. The Journal of Sexual Medicine 16:3, pages 452-462.
Crossref
Crossref
Karol Gliniewicz, G. Maria Schneider, Benjamin J. Ridenhour, Christopher J. Williams, Yuli Song, Miranda A. Farage, Kenneth Miller & Larry J. Forney. (2019) Comparison of the Vaginal Microbiomes of Premenopausal and Postmenopausal Women. Frontiers in Microbiology 10.
Crossref
Crossref
Lisa Larkin & Sheryl A. Kingsberg. (2019) The unintended sexual health consequences of risk-reducing surgery: we must do more!. Menopause 26:2, pages 118-120.
Crossref
Crossref
Hasan Çilgin. (2019) Predictors of Initiating Hormone Replacement Therapy in Postmenopausal Women: A Cross-Sectional Study. The Scientific World Journal 2019, pages 1-8.
Crossref
Crossref
Cemal Tamer Erel. 2019. Postmenopausal Diseases and Disorders. Postmenopausal Diseases and Disorders
187
203
.
Holly N. Thomas. (2018) High and dry: recognizing the impact of genitourinary syndrome of menopause. Menopause 25:12, pages 1401-1402.
Crossref
Crossref
Eloy Moral, Juan L. Delgado, Francisco Carmona, Borja Caballero, Cristina Guillán, Paula M. González, Javier Suárez-AlmarzaSyra Velasco-OrtegaConcepción Nieto Magro. (2018) The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women. Menopause 25:12, pages 1418-1423.
Crossref
Crossref
Caroline M. Mitchell & L. Elaine Waetjen. (2018) Genitourinary Changes with Aging. Obstetrics and Gynecology Clinics of North America 45:4, pages 737-750.
Crossref
Crossref
Woong-Geun Kang. (2018) Effects of Stepper Exercise on Physical Fitness and Blood Lipids in Pre-and Post-Menopausal Obese Women. Korean Journal of Sport Studies 57:6, pages 273-283.
Crossref
Crossref
Raffaela Di Pace & Rosalba Portuesi. (2018) Vaginal health index score and urogenital syndrome of menopause. Gazzetta Medica Italiana Archivio per le Scienze Mediche 177:12.
Crossref
Crossref
Rebecca M. Brotman, Michelle D. Shardell, Pawel Gajer, Doug Fadrosh, Kathryn Chang, Michelle I. Silver, Raphael P. Viscidi, Anne E. Burke, Jacques RavelPatti E. Gravitt. (2018) Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 25:11, pages 1321-1330.
Crossref
Crossref
I. Jardin, G. Canlorbe, J.-L. Mergui, M. Nikpayam, J. Belghiti, C. Uzan & H. Azaïs. (2018) Place du LASER au CO2 pour le traitement des symptômes vaginaux du syndrome génito-urinaire de la ménopause. Gynécologie Obstétrique Fertilité & Sénologie 46:10-11, pages 729-734.
Crossref
Crossref
Ashley L. Hodges, Aimee C. Holland, Barbara Dehn & Diane T. Pace. (2018) Diagnosis and Treatment of Genitourinary Syndrome of Menopause. Nursing for Women's Health 22:5, pages 423-430.
Crossref
Crossref
Joan Pitkin. (2018) BMS – Consensus statement. Post Reproductive Health 24:3, pages 133-138.
Crossref
Crossref
Sharon J. Parish, Rossella E. Nappi & Sheryl Kingsberg. (2018) Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment. Menopause 25:8, pages 937-949.
Crossref
Crossref
Emmanuele A. Jannini & Rossella E. Nappi. (2018) Couplepause: A New Paradigm in Treating Sexual Dysfunction During Menopause and Andropause. Sexual Medicine Reviews 6:3, pages 384-395.
Crossref
Crossref
Seetesh Ghose, Rupal Samal & Palai Pallavee. (2018) Recent Advances in the Management for Genitourinary Syndrome of Menopause. Journal of SAFOMS 6:1, pages 65-68.
Crossref
Crossref
Stephanie S. Faubion, Lisa C. Larkin, Cynthia A. Stuenkel, Gloria A. Bachmann, Lisa A. Chism, Risa Kagan, Andrew M. Kaunitz, Michael L. Krychman, Sharon J. Parish, Ann H. Partridge, JoAnn V. Pinkerton, Tami S. Rowen, Marla Shapiro, James A. Simon, Shari B. Goldfarb & Sheryl A. Kingsberg. (2018) Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health. Menopause 25:6, pages 596-608.
Crossref
Crossref
Patrizia Monteleone, Giulia Mascagni, Andrea Giannini, Andrea R. Genazzani & Tommaso Simoncini. (2018) Symptoms of menopause — global prevalence, physiology and implications. Nature Reviews Endocrinology 14:4, pages 199-215.
Crossref
Crossref
Displaying 200 of 296 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list